BCM
NBEV

Bayesian Capital Management’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bayesian Capital Management’s Portfolio NBEV Stock Details NBEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-56,900
Closed -$296K – 815
2018
Q4 		$296K Buy
+56,900
New +$298K 0.06% 417

Other funds holding NBEV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Bayesian Capital Management's NBEV Position: Q1 2019 in Review

Bayesian Capital Management sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q1 2019, closing a stake of 56,900 shares — an estimated $296K sold.

Bayesian Capital Management first reported a position in NBEV in Q4 2018 and held it in 1 quarter. The position peaked at $296K in Q4 2018. 95 funds tracked by Wall St. Rank hold NBEV as of Q1 2019.

  • Bayesian Capital Management reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q1 2019 after selling out during the quarter.
  • Bayesian Capital Management sold 56,900 NewAge, Inc. Common Stock (Delaware) shares in Q1 2019, an estimated $296K.
  • Bayesian Capital Management first reported a position in NewAge, Inc. Common Stock (Delaware) in Q4 2018 and held it in 1 quarter.
  • Bayesian Capital Management's NewAge, Inc. Common Stock (Delaware) position peaked at $296K in Q4 2018.
  • 95 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q1 2019.

Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.